{
  "retracted": false,
  "timestamp": 1196467200000,
  "updates": [
    {
      "timestamp": 1555504865040,
      "identifier": {
        "doi": "10.1038/nbt1207-1488a"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/nbt0907-951"
  },
  "journal": "Nature Biotechnology",
  "publisher": "Springer Nature",
  "title": "Erratum: Funding crunch forces stem cell company to abandon therapies"
}
